In general, and similar to FDA-approved labeling for GLP-1 weight-management medications, you may be considered for a GLP-1 prescription if you: Have a BMI of 30 or higher (obesity), or Have a BMI between 2729.9 (overweight) plus a weight-related health condition Weight-related conditions can include high blood pressure, type 2 diabetes, sleep apnea, high cholesterol, or PCOS (Polycystic Ovary Syndrome), for example
If you are pregnant or plan to become pregnant
Current UK guidance from the MHRA and manufacturer clearly states that Wegovy (semaglutide 2.4 mg) should not be used during lactation due to insufficient data on its transfer into breast milk and potential effects on nursing infants
Lemonaid Medical Team Quality care, patient-first providers Youll always feel seen and heard with our team of U.S.-licensed medical providers
But context matters enormously